Lung Cancer Location: a Repository
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00578084 |
Recruitment Status
:
Terminated
First Posted
: December 20, 2007
Last Update Posted
: October 8, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Lung Cancer |
Study Type : | Observational |
Estimated Enrollment : | 200 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Lung Cancer Location: A Prospective Repository |
Study Start Date : | June 2006 |
Actual Primary Completion Date : | July 2013 |
Actual Study Completion Date : | September 2013 |

Group/Cohort |
---|
surgery
those subjects who went to surgery to treat their lung cancer
|
no surgery
those subjects who did not go to surgery for their lung cancer
|
NSCLC
subjects with NSCLC
|
Small cell lung cancer
those with small cell lung cancer
|
- examine subjects with known or suspected lung cancer to determine the extent of mediastinal lymph node involvement with respect to primary lung cancer location [ Time Frame: ongoing-database ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subjects undergoing EUS evaluation of a mediastinal mass, or suspected/known lung cancer
- Subjects with a prior history of lung cancer
- Subjects referred to thoracic surgery for evaluation of a suspected/known lung cancer
Exclusion Criteria:
- Altered mental status that would prohibit the giving and understanding of informed consent
- Dementia
- Psychiatric illness that would preclude adequate compliance with communication for this protocol
- Prisoners

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00578084
United States, Indiana | |
Clarian/IUPUI: University Hospital | |
Indianapolis, Indiana, United States, 46202 |
Principal Investigator: | Julia LeBlanc, MD, MPH | Indiana University |
Responsible Party: | Indiana University |
ClinicalTrials.gov Identifier: | NCT00578084 History of Changes |
Other Study ID Numbers: |
0604-76 IRB # 0604-76 |
First Posted: | December 20, 2007 Key Record Dates |
Last Update Posted: | October 8, 2013 |
Last Verified: | September 2013 |
Additional relevant MeSH terms:
Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site |
Neoplasms Lung Diseases Respiratory Tract Diseases |